News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
868,161 Results
Type
Article (87831)
Company Profile (824)
Press Release (779492)
Multimedia
Podcasts (188)
Webinars (28)
Section
Business (233192)
Career Advice (4144)
Deals (39852)
Drug Delivery (145)
Drug Development (91385)
Employer Resources (203)
FDA (18371)
Job Trends (17415)
News (397781)
Policy (39955)
Tag
Academia (3006)
Academic (2)
Accelerated approval (31)
Adcomms (36)
Allergies (138)
Alliances (56981)
ALS (176)
Alzheimer's disease (1774)
Antibody-drug conjugate (ADC) (319)
Approvals (18526)
Artificial intelligence (588)
Autoimmune disease (145)
Automation (34)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (198)
Biotechnology (488)
Bladder cancer (155)
Brain cancer (63)
Breast cancer (634)
Cancer (4820)
Cardiovascular disease (422)
Career advice (3566)
Career pathing (40)
CAR-T (296)
CDC (59)
Celiac Disease (1)
Cell therapy (799)
Cervical cancer (37)
Clinical research (76751)
Collaboration (1662)
Company closure (5)
Compensation (1106)
Complete response letters (68)
COVID-19 (2984)
CRISPR (94)
C-suite (783)
Cystic fibrosis (149)
Data (6025)
Decentralized trials (2)
Denatured (69)
Depression (138)
Diabetes (511)
Diagnostics (7192)
Digital health (43)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (288)
Drug pricing (212)
Drug shortages (36)
Duchenne muscular dystrophy (228)
Earnings (99923)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134775)
Executive appointments (1013)
FDA (21362)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (22)
Funding (1469)
Gene editing (205)
Generative AI (60)
Gene therapy (641)
GLP-1 (1101)
Government (5429)
Grass and pollen (8)
Guidances (381)
Healthcare (20941)
HIV (56)
Huntington's disease (46)
IgA nephropathy (83)
Immunology and inflammation (281)
Immuno-oncology (45)
Indications (80)
Infectious disease (3260)
Inflammatory bowel disease (199)
Inflation Reduction Act (17)
Influenza (116)
Intellectual property (229)
Interviews (816)
IPO (17948)
IRA (60)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (653)
Leadership (39)
Legal (10156)
Liver cancer (96)
Longevity (14)
Lung cancer (661)
Lymphoma (368)
Machine learning (40)
Management (66)
Manufacturing (779)
MASH (170)
Medical device (14990)
Medtech (15033)
Mergers & acquisitions (22917)
Metabolic disorders (1334)
Multiple sclerosis (155)
NASH (23)
Neurodegenerative disease (330)
Neuropsychiatric disorders (90)
Neuroscience (3016)
NextGen: Class of 2026 (7704)
Non-profit (5107)
Now hiring (62)
Obesity (642)
Opinion (329)
Ovarian cancer (158)
Pain (194)
Pancreatic cancer (214)
Parkinson's disease (281)
Partnered (37)
Patents (482)
Patient recruitment (440)
Peanut (59)
People (66723)
Pharmaceutical (145)
Pharmacy benefit managers (31)
Phase I (23709)
Phase II (33301)
Phase III (25113)
Pipeline (4292)
Policy (325)
Postmarket research (3554)
Preclinical (10677)
Press Release (72)
Prostate cancer (234)
Psychedelics (53)
Radiopharmaceuticals (295)
Rare diseases (833)
Real estate (7437)
Recruiting (80)
Regulatory (28748)
Reports (65)
Research institute (2719)
Resumes & cover letters (651)
Rett syndrome (25)
RNA editing (16)
RSV (82)
Schizophrenia (153)
Series A (244)
Series B (180)
Service/supplier (30)
Sickle cell disease (102)
Special edition (27)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4329)
State (2)
Stomach cancer (19)
Supply chain (110)
Tariffs (97)
The Weekly (117)
Vaccines (1117)
Venture capital (84)
Weight loss (445)
Women's health (81)
Worklife (21)
Date
Today (221)
Last 7 days (471)
Last 30 days (2027)
Last 365 days (33377)
2026 (471)
2025 (33229)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (334)
Arkansas (14)
Asia (51435)
Australia (9025)
California (11057)
Canada (3221)
China (1104)
Colorado (467)
Connecticut (485)
Delaware (334)
Europe (118138)
Florida (1622)
Georgia (355)
Hawaii (3)
Idaho (68)
Illinois (920)
India (63)
Indiana (527)
Iowa (23)
Japan (405)
Kansas (131)
Kentucky (42)
Louisiana (29)
Maine (81)
Maryland (1416)
Massachusetts (8197)
Michigan (348)
Minnesota (639)
Mississippi (6)
Missouri (136)
Montana (34)
Nebraska (28)
Nevada (120)
New Hampshire (82)
New Jersey (3011)
New Mexico (32)
New York (2949)
North Carolina (1558)
North Dakota (10)
Northern California (5239)
Ohio (337)
Oklahoma (22)
Oregon (53)
Pennsylvania (2229)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (62)
South Dakota (1)
Southern California (4253)
Tennessee (170)
Texas (1748)
United States (40173)
Utah (331)
Vermont (1)
Virginia (277)
Washington D.C. (85)
Washington State (933)
West Virginia (4)
Wisconsin (119)
Wyoming (2)
There are 868,161 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Insights
Biotech Investors Bet on a 2026 Rebound as Deal Activity Accelerates
After a prolonged funding chill, investors say 2026 is shaping up for continued dealmaking and diversified bets beyond oncology and immunology.
January 7, 2026
·
3 min read
·
Jennifer Smith-Parker
Press Releases
Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia
January 7, 2026
·
4 min read
Press Releases
Vivoryon Therapeutics N.V. to Attend and Present in Upcoming Conferences
January 7, 2026
·
3 min read
Press Releases
JJP Biologics Announces Positive Top-Line Phase I Trial Results of JJP-1212, its anti-CD89 antagonist
January 7, 2026
·
8 min read
Press Releases
Basilea and Prokaryotics enter collaboration to develop a novel broad-spectrum antifungal for the treatment of severe invasive infections
January 7, 2026
·
5 min read
Press Releases
Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering
January 7, 2026
·
4 min read
Press Releases
Kelun-Biotech to Attend the 44th J.P. Morgan Healthcare Conference, Sharing Its Business Progresses and Innovation Strategies
January 7, 2026
·
2 min read
Press Releases
Ivonescimab’s Updated Label Shows Positive Dual Results in PFS and OS from HARMONi-A Study
January 7, 2026
·
5 min read
Press Releases
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
January 7, 2026
·
6 min read
Press Releases
Celltrion to present at the 44th Annual J.P. Morgan Healthcare Conference
January 7, 2026
·
1 min read
1 of 86,817
Next
